Prothena Corporation plc - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
PRTA Nasdaq 2830 www.prothena.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Prothena Corporation plc

Adaptive Biotechnologies (ADPT) Moves 9.7% Higher: Will This Strength Last? - Jun 12th, 2026 3:44 am
High Insider Ownership Growth Stocks To Watch In May 2026 - May 28th, 2026 11:35 am
Earnings Beat: Prothena Corporation plc Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models - May 11th, 2026 7:17 am
Prothena Reports First Quarter 2026 Financial Results and Business Highlights - May 7th, 2026 2:05 pm
Prothena to Report First Quarter 2026 Financial Results on May 7 - Apr 30th, 2026 2:05 pm
Stock Market Today, April 29: KalVista Pharmaceuticals Surges on Chiesi Group Acquisition Announcement - Apr 29th, 2026 4:07 pm
3 Growth Companies Insiders Are Eager To Hold - Apr 29th, 2026 5:36 am
Prothena Announces Novo Nordisk Obtains Fast Track Designation from the U.S. FDA for Coramitug (PRX004) in ATTR Amyloidosis with Cardiomyopathy - Apr 27th, 2026 2:05 pm
Prothena Announces Leadership Team Updates - Apr 10th, 2026 2:05 pm
AZN Posts Data From Hypophosphatasia Program on Efzimfotase Alfa - Apr 1st, 2026 9:04 am
Top Growth Companies With High Insider Ownership In March 2026 - Mar 31st, 2026 11:36 am
Sanofi Gets EU Nod for Rezurock in Chronic Graft-Vs-Host Disease - Mar 31st, 2026 10:12 am
RCKT Stock Down Despite FDA Nod to Gene Therapy in Rare Disease - Mar 30th, 2026 10:16 am
Why Is Sarepta Therapeutics (SRPT) Up 24.2% Since Last Earnings Report? - Mar 27th, 2026 9:30 am
Why Is Jazz (JAZZ) Down 3.9% Since Last Earnings Report? - Mar 26th, 2026 9:30 am
Wall Street Analysts Think Prothena (PRTA) Could Surge 120.19%: Read This Before Placing a Bet - Mar 26th, 2026 7:55 am
Prothena Partners Present Data Supporting Next Generation Treatments for Parkinson’s and Alzheimer’s Disease at AD/PD™ 2026 - Mar 21st, 2026 2:05 pm
Prothena Announces Achievement of $50 Million Clinical Milestone Payment from Novo Nordisk Related to Ongoing Phase 3 Clinical Trial for Coramitug (Formerly PRX004) in ATTR Amyloidosis with Cardiomyopathy - Mar 9th, 2026 2:05 pm
Wall Street Analysts Believe Prothena (PRTA) Could Rally 118.09%: Here's is How to Trade - Mar 3rd, 2026 7:55 am
Prothena Announces up to $100 Million Share Repurchase Plan - Feb 27th, 2026 2:15 pm